Lakewood-Amedex Biotherapeutics Inc (LABT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 12-2000 | 09-2000 | 06-2000 | 03-2000 | 12-1999 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 2,660 | 2,080 | 1,910 | 2,020 | 1,600 |
| TOTAL | $2,660 | $2,080 | $1,910 | $2,020 | $1,600 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 20,270 | 20,640 | 21,020 | 21,440 | 23,180 |
| TOTAL | $20,270 | $20,640 | $21,020 | $21,440 | $23,180 |
| Total Assets | $22,930 | $22,720 | $22,930 | $23,460 | $24,780 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,730 | 2,730 | 2,680 | 2,900 | 2,850 |
| Accounts payable and accrued liabilities | 17,110 | 10,400 | 12,360 | 9,410 | 10,950 |
| Accrued Expenses | 2,460 | 3,570 | 2,480 | 3,150 | 2,920 |
| TOTAL | $40,390 | $32,430 | $28,960 | $26,400 | $25,920 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $40,390 | $32,430 | $28,960 | $26,400 | $25,920 |
| Shareholders' Equity | |||||
| Common Shares | 40 | 40 | 40 | 40 | 40 |
| Other shareholders' equity | -30 | -40 | -30 | -40 | -60 |
| TOTAL | $23,840 | $23,830 | $23,830 | $23,800 | $23,780 |
| Total Liabilities And Equity | $64,230 | $56,260 | $52,790 | $50,200 | $49,700 |